ArticleChemistry & biodiversity2026
ent-Atisane Diterpenoids From Euphorbia micractina and Their Cytotoxic Activity.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Three new ent-atisane diterpenoids (1-3) and five known ones (4-8) were obtained from the bioactive fraction of E. micractina. Their structures and absolute configurations were elucidated by a comprehensive analysis of the spectroscopic data, including high-resolution electrospray ionization mass spectrometry, infrared, nuclear magnetic resonance, X-ray crystallography, and electronic circular dichroism data. Among them, compound 1 was the first example of an ent-atisane diterpenoid with an α-oriented hydroxyl group at C-7. In addition, the cytotoxicity of all the isolated ent-atisane diterpenoids was evaluated against human cervical carcinoma, human acute promyelocytic leukemia, and human hepatoma cell lines. Compound 3 demonstrated significant cytotoxic activity against the selected cell lines with an IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.